
Keywords: آدنوکارسینوم پستان; magnetic nanoparticles; drug delivery; chemotherapy; MRI-contrast agents; breast adenocarcinoma; iron oxide; BSA; bovine serum albumin; MNP; PEGylated albumin coated magnetic nanoparticles; VEGF; vascular endothelial growth factor; Dox; doxorubicin; MRI;